[Form 4] BKV Corporation Insider Trading Activity

Rhea-AI Filing Summary

On July 1, 2025, BKV Corp’s Chief Legal and Administrative Officer, Lindsay B. Larrick, sold 10,000 shares of BKV common stock at a weighted-average price of $23.1307 under a pre-arranged Rule 10b5-1 trading plan adopted on November 22, 2024. Following the sale, the officer continues to hold 210,528 shares, representing a reduction of roughly 4.5% of her prior direct holding. No derivative transactions were reported. The filing is a routine Form 4 disclosure required under Section 16(a) and does not, by itself, indicate any change to BKV’s fundamentals or strategy.

Positive

• None.

Negative

• Insider selling: Senior officer disposed of 10,000 shares, which can be interpreted by some investors as a modestly bearish signal despite being under a 10b5-1 plan.

Insights

Corporate Governance Expert

TL;DR: Routine 10b5-1 sale; minimal governance impact.

This sale was executed under a disclosed 10b5-1 plan, signalling that the officer pre-committed to the transaction, thereby reducing the likelihood of information-driven trading concerns. The amount—10,000 shares—is modest relative to both total shares outstanding and the insider’s remaining stake of 210,528 shares. No red flags such as clustered executive selling or departures accompany the filing, so governance risk remains low.

Portfolio Manager

TL;DR: Insider sale is small; portfolio impact negligible.

The transaction equates to roughly $231k in proceeds and trims the officer’s position by about 4–5%. For a company of BKV’s market capitalisation, this is immaterial to valuation or liquidity. Because the sale follows a 10b5-1 plan, it offers little insight into management’s sentiment beyond routine diversification. I would not adjust position sizing or valuation models based solely on this Form 4.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Larrick Lindsay B

(Last) (First) (Middle)

1200 17TH STREET, SUITE 2100

(Street)

DENVER CO 80202

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
BKV Corp [ BKV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Legal and Admin Officer

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/01/2025		S(1)		10,000	D	$23.1307(2)	210,528	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 22, 2024.

2. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $22.7100 to $23.5300, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Remarks:

	/s/ Kathleen Lenox, attorney-in-fact	07/01/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many BKV shares did insider Lindsay B. Larrick sell?

She sold 10,000 common shares on July 1, 2025.

What price did the BKV shares sell for?

The weighted-average sale price was $23.1307, with individual trades ranging from $22.71 to $23.53.

How many BKV shares does the officer still own after the sale?

Following the transaction, the officer holds 210,528 shares directly.

Was the sale made under a Rule 10b5-1 trading plan?

Yes. The officer adopted the 10b5-1 plan on November 22, 2024 and executed the sale pursuant to that plan.

Does this Form 4 indicate any changes to BKV’s operations or earnings?

No. The filing solely reports an insider share sale and contains no operational or earnings information.